Patent Daily RSS
April 2020 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Twitter Guna
- Happy #gobackmodi day 1 year ago
- RT @nikhilkarani1: Aurobindo acquires oral solid & derm Biz of Sandoz - Acqd Biz has sales worth $1.2bn & Aurobindo wud pay $900mn in cash… 1 year ago
- RT @ainvvy: 0. On Independence day, I look briefly at how some of the current states came into being. Some of them I had not even heard be… 1 year ago
- RT @digvijaya_28: Political turmoil in TN and Governor playing truant. Is he fulfilling his duties ? No. He is doing politics under directi… 3 years ago
- RT @VikasDandekarET: #Cipla bets on speciality #pharma business in US; aims for commercial launches by 2020 economictimes.indiatimes.com/industry/healt… 3 years ago
- RT @scarthik: @itisprashanth வாழ்வில் நமதுதேவை குறித்த தெளிவான தேர்வும், அதைநோக்கிய நேர்மையான தேடலும்இருந்துவிட்டால், வெற்றி கூடிவரும். அமை… 4 years ago
Tag Archives: Chandix
India: Varenacline Patent revoked
Varenaciline is marketed by Pfizer world wide as Chandix or Champix. Varenaciline is marketed as tartarate salt form, this salt form is protected by US patent 6890927 and its indian equivalent is 204091 (863/MUMNP/2003). This ‘091 patent is opposed by Dr … Continue reading
Posted in Patent case
Tagged 204091, 863/MUMNP/2003, Champix, Chandix, Dr Reddy's, pfizer
Leave a comment
